Tao Chunrong, Simpson Steve, Taylor Bruce V, Blizzard Leigh, Lucas Robyn M, Ponsonby Anne-Louise, Broadley Simon, van der Mei Ingrid
Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia.
Institute for Health & Ageing, Australian Catholic University, Melbourne, VIC, Australia.
Front Neurol. 2018 Jun 8;9:418. doi: 10.3389/fneur.2018.00418. eCollection 2018.
Age at symptom onset (ASO) is a prognostic factor that could affect the accrual of disability in multiple sclerosis (MS) patients. Some factors are known to influence the risk of multiple sclerosis (MS), but their influence on the ASO is less well-investigated. Examine the associations between known or emerging MS risk factors and ASO. This was a multicenter study, incident cases ( = 279) with first clinical diagnosis of demyelinating event aged 18-59 years recruited at four Australian centres (latitudes 27°-43°S), from 1 November 2003 to 31 December 2006. Environmental/behavioral variables and initial symptoms were recorded at baseline interview. Linear regression was used to assess the association between risk factors and ASO. Five factors were significantly associated with ASO: a history of tobacco smoking was associated with 3.05-years later ASO ( = 0.002); a history of marijuana use was associated with 6.03-years earlier ASO ( < 0.001); progressive-onset cases had 5.61-years later ASO ( = 0.001); an initial presentation of bowel & bladder and cerebral dysfunctional were associated with 3.39 ( = 0.017) and 4.37-years ( = 0.006) later ASO, respectively. Other factors, including sex, offspring number, latitude of study site, history of infectious mononucleosis, genotype, 25(OH)D levels, and ultraviolet radiation exposure were not associated with ASO. Including all five significant variables into one model explained 12% of the total variance in ASO. We found a novel association between a history of tobacco smoking and later onset, whereas marijuana use was associated with earlier onset. Behavioral factors seem important drivers of MS onset timing although much of the variance remains unexplained.
症状出现年龄(ASO)是一个预后因素,可能会影响多发性硬化症(MS)患者残疾的累积。已知一些因素会影响多发性硬化症(MS)的风险,但它们对ASO的影响研究较少。研究已知或新出现的MS风险因素与ASO之间的关联。这是一项多中心研究,从2003年11月1日至2006年12月31日,在澳大利亚四个中心(南纬27°-43°)招募了年龄在18-59岁之间、首次临床诊断为脱髓鞘事件的279例新发病例。在基线访谈时记录环境/行为变量和初始症状。采用线性回归评估风险因素与ASO之间的关联。有五个因素与ASO显著相关:吸烟史与ASO延迟3.05年相关(P=0.002);使用大麻史与ASO提前6.03年相关(P<0.001);渐进性起病病例的ASO延迟5.61年(P=0.001);肠道和膀胱及脑功能障碍的初始表现分别与ASO延迟3.39年(P=0.017)和4.37年(P=0.006)相关。其他因素,包括性别、子女数量、研究地点的纬度、传染性单核细胞增多症病史、基因型、25(OH)D水平和紫外线辐射暴露与ASO无关。将所有五个显著变量纳入一个模型可解释ASO总方差的12%。我们发现吸烟史与发病延迟之间存在新的关联,而使用大麻与发病提前相关。行为因素似乎是MS发病时间的重要驱动因素,尽管大部分方差仍无法解释。